Clinical Trials in California

Showing 4201-4220 of 11,359 trials

Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers

NCT05506215

The study will evaluate the efficacy of SynPath™, a synthetic dermal matrix, in the treatment of diabetic foot ulcers in subjects with diabetes mellitus versus Standard of Care treatment. Half the subjects with be treated using SynPath™ while the other half will receive Standard of Care treatment

Diabetic FootChronic Foot UlcerWound Healing+1 more

PolyNovo Biomaterials Pty Ltd.25 participantsStarted Jul 2022

Castro Valley, California, United States • Fresno, California, United States • Vista, California, United States +4 more locations

WITHDRAWNPhase 144 miles

A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

NCT03938922

This study will be conducted as a multi-center, open label study in the US. There will be 40 patient to receive the active investigational product.

Parkinson DiseaseDementia

Enterin Inc.Started Mar 2024

Fresno, California, United States • Toms River, New Jersey, United States • Dayton, Ohio, United States

COMPLETEDPhase 3108 miles

Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

NCT04140227

The objectives of this trial are to evaluate the safety and tolerability of perfluorohexyloctane (NOV03) ophthalmic solution during long-term use in subjects with Dry Eye Disease (DED) associated with MGD (Meibomian Gland Dysfunction). Further objective is to evaluate the efficacy of perfluorohexyloctane (NOV03) solution during long-term use in subjects with DED associated with MGD.

Dry Eye Disease (DED)

Bausch & Lomb Incorporated256 participantsStarted Sep 2020

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Glendale, California, United States +25 more locations

Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers

A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

Find Trials by Condition in California

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

A Clinical Utility Study of PrismRA for Rheumatoid Arthritis

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma

A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)

Strategic Timing of Antiretroviral Treatment

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

OCS Lung System EXPAND II Trial

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)